These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The neurofibromatosis type 2 gene is inactivated in schwannomas. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA. Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016 [Abstract] [Full Text] [Related]
3. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Hadfield KD, Smith MJ, Urquhart JE, Wallace AJ, Bowers NL, King AT, Rutherford SA, Trump D, Newman WG, Evans DG. Oncogene; 2010 Nov 25; 29(47):6216-21. PubMed ID: 20729918 [Abstract] [Full Text] [Related]
4. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM. Hum Mol Genet; 1994 Jun 25; 3(6):885-91. PubMed ID: 7951231 [Abstract] [Full Text] [Related]
5. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJ, Kley N. Am J Hum Genet; 1994 Jun 25; 54(6):1022-9. PubMed ID: 7911002 [Abstract] [Full Text] [Related]
6. Analysis of mutations in the SCH gene in schwannomas. Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ. Genes Chromosomes Cancer; 1994 Sep 25; 11(1):7-14. PubMed ID: 7529050 [Abstract] [Full Text] [Related]
7. Frequency of the Loss of Heterozygosity of the NF2 Gene in Sporadic Spinal Schwannomas. DE Carvalho RM, DE Castro Sant' Anna C, Pinto GR, Paschoal EHA, Tuji FM, DO Nascimento Borges B, Soares PC, Júnior AGF, Rey JA, Chaves LCL, Burbano RR. Anticancer Res; 2018 Apr 25; 38(4):2149-2154. PubMed ID: 29599333 [Abstract] [Full Text] [Related]
8. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas. Leone PE, Bello MJ, Mendiola M, Kusak ME, De Campos JM, Vaquero J, Sarasa JL, Pestana A, Rey JA. Int J Mol Med; 1998 May 25; 1(5):889-92. PubMed ID: 9852312 [Abstract] [Full Text] [Related]
9. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene. Bruder CE, Ichimura K, Tingby O, Hirakawa K, Komatsuzaki A, Tamura A, Yuasa Y, Collins VP, Dumanski JP. Hum Genet; 1999 May 25; 104(5):418-24. PubMed ID: 10394935 [Abstract] [Full Text] [Related]
10. Exon scanning for mutation of the NF2 gene in schwannomas. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V. Hum Mol Genet; 1994 Mar 25; 3(3):413-9. PubMed ID: 8012353 [Abstract] [Full Text] [Related]
11. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, Montali E, Papi L. Hum Genet; 1996 May 25; 97(5):632-7. PubMed ID: 8655144 [Abstract] [Full Text] [Related]
12. Comparative genomic hybridization and mutation analyses of sporadic schwannomas. Ikeda T, Hashimoto S, Fukushige S, Ohmori H, Horii A. J Neurooncol; 2005 May 25; 72(3):225-30. PubMed ID: 15937644 [Abstract] [Full Text] [Related]
13. Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas. Welling DB, Guida M, Goll F, Pearl DK, Glasscock ME, Pappas DG, Linthicum FH, Rogers D, Prior TW. Hum Genet; 1996 Aug 25; 98(2):189-93. PubMed ID: 8698340 [Abstract] [Full Text] [Related]
14. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells. Bian LG, Sun QF, Tirakotai W, Zhao WG, Shen JK, Luo QZ, Bertalanffy H. Chin Med J (Engl); 2005 Sep 20; 118(18):1517-24. PubMed ID: 16232328 [Abstract] [Full Text] [Related]
15. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G. Genes Dev; 2000 Jul 01; 14(13):1617-30. PubMed ID: 10887156 [Abstract] [Full Text] [Related]
16. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP. Neurosurgery; 1995 Oct 01; 37(4):764-73. PubMed ID: 8559307 [Abstract] [Full Text] [Related]
17. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases. Lasota J, Wasag B, Dansonka-Mieszkowska A, Karcz D, Millward CL, Ryś J, Stachura J, Sobin LH, Miettinen M. Lab Invest; 2003 Sep 01; 83(9):1361-71. PubMed ID: 13679444 [Abstract] [Full Text] [Related]
18. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Hum Mol Genet; 1994 Feb 01; 3(2):347-50. PubMed ID: 8004107 [Abstract] [Full Text] [Related]
19. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis. Jacoby LB, MacCollin M, Parry DM, Kluwe L, Lynch J, Jones D, Gusella JF. Neurogenetics; 1999 Apr 01; 2(2):101-8. PubMed ID: 10369886 [Abstract] [Full Text] [Related]
20. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas. Hung G, Faudoa R, Baser ME, Xue Z, Kluwe L, Slattery W, Brackman D, Lim D. Cancer Genet Cytogenet; 2000 Apr 15; 118(2):167-8. PubMed ID: 10748301 [Abstract] [Full Text] [Related] Page: [Next] [New Search]